produced by a strain of Staphylococcus epidermidis, is described. The name mycobactocidin is proposed because of the specificity of the antibiotic against mycobacteria. Methods for extraction and purification of the antibiotic are described. The water-soluble fraction is shown to be active in vitro. No toxicity could be detected in mice after intraperitoneal or subcutaneous injection. Enzymatic hydrolysis suggests a glyco-protein nature for the antibiotic. Mycobactocidin is soluble in distilled water at neutrality but is generally insoluble in organic solvents. The antibiotic is precipitated from aqueous solution by heavy metals. Itis stable in the pH range of 2 to 8, but is precipitated at pH 3 to 4. An aqueous solution of the antibiotic is stable for several days at 5 C, and for longer periods if lyophilized and stored at -20 C. It does not pass through a dialysis membrane and its activity is retained after 15 to 20 hr of dialysis at 5 C. The activity was shown to be unrelated to the formation of hydrogen peroxide.
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During studies on colony morphology of mycobacteria, the observation of a growth-stimulating effect on a scotochromogenic strain of mycobacterium produced by a contaminant was made. Subsequent work led to the identification of the organism as Staphylococcus epidermidis and to the description of a new antibiotic with an activity spectrum apparently limited to mycobacteria. Magrassi and Spiga (1946) reported on an antibiotic produced by a strain of S. aureus, but a toxic substance was associated with the active principle and could not be separated. Jen-1 Present address: Istituto di Microbiologia, Universita di Bologna, Bologna, Italy. nings and Sharp (1947) found that 26 strains (including 6 S. albus) of 205 Staphylococcus strains tested were active in streak tests against S. aureus, Corynebacterium xerosis, C. diptheriae gravis, mitis, and intermedius, and C. hoffmanii, and ineffective against Escherichia coli, Pseudomonas aeruginosa, and Salmonella enteriditis. Gardner (1949) reported an antibiotic produced by S. aureus active against Bacillus anthracis, C. xerosis, S. aureus, Streptococcus pyogenes, Mlicrococcus lysodeikticus, and Mycobacterium phlei, and inactive against C. diphtheriae intermedius, E. coli, M. smegmatis, P. aeruginosa, S. enteriditis, and Shigella sonnei. Vanbreuseghem (1948) and Krassilnikov and Koreniako (1939) also noted some antibiotic activity of S. aureus.
MATERIALS AND METHODS
Medium. For the preparation of the antibiotic, this strain of S. epidermidis was grown in mass culture on oleic acid-albumin agar (OAA agar) containing 0.1% cycloheximide (The Upjohn Co., Kalamazoo, Mich.) or on the same medium without albumin or cycloheximide.
Test organisms. The test organisms used are listed in Table 1 . The original observation ( Fig. 1 ) and successive studies were done with a scot,)-chromogenic strain of mycobacterium (B-263', Techniques for in vitro assay of antibiotic activity. OAA agar plates were inoculated by streaking S. epidermidis across the diameter. After incubation overnight, selected test organisms were streaked at right angles on both sides of the primary streak (Fig. 2) . The plates were further incubated, with daily examination for the appearance of inhibition.
When the test organism was B-263, usually a drop of a saline suspension of a 24-hr culture of S. epidermidis was deposited on the center of the agar previously seeded with the test strain.
Extracts of S. epidermidis were tested by depositing two drops of the appropriate dilution either on small filter discs (13 mm diam) or in for antibiotic activity. The second and third eluates were the only ones that showed activity against B-263.
RESULTS
Identification of the antibiotic producing strain as Staphylococcus epidermidis. A stained smear of a 24-hr culture was composed of clusters of grampositive cocci. The organism produced acid from mannose, galatose, lactose, maltose, and saccharose, but failed to ferment xylose, arabinose, inulin, sorbitol, or mannitol. Colonies on blood agar were large, creamy, smooth, and nonhemolytic, growing at both 25 and 37 C. On Loeffler's medium, the growth was creamy white. Growth occurred on agar medium containing 7.5% NaCI. The organism is coagulase negative Figure 5 shows the enhancement produced by S. N. J. epidermidis on strain B-263 when the plates were.
b Symbols: + = full antibiotic activity; i = seeded too heavily with the mycobacterium. It reduction of activity;-= complete inhibition of was also seen that the time of inoculation plays an activity. important role in the antibiotic activity of S.
c Nutritional Biochemicals Corp., Cleveland, epidermidis. It is possible to obtain inhibition, or Ohio. inhibition and enhancement, or enhancement d Enzyme added to the solution after 2 hr of alone, depending on the timing of the inoculation incubation at 37 C, and incubated for another with staphylococci and B-263 (Fig. 6) . Figure 6a -shows the result of simultaneous seeding: a large inhibition zone surrounded by a narrow band of enhanced growth. Figure 6b demonstrates the reduction in size of the inhibition zone and the increase in the enhancement zone when the Mycobacterium is seeded 6 days before the antibiotic-producing strain. Finally, Fig. 6c illustrates that only enhancement is produced when S. epidermidis is seeded on a 10-day culture of Mycobacterium. Purification and activtity of the extracts. A 7-to 10-day culture of S. epidermidis on OAA agar was extracted according to the scheme shown in Fig. 3 . The fractions shown to be active were B, D, I, J, and K (Fig. 7) ; a factor common to all tof these was solubility in water at neutral pH. Fractions B and D were the most active. All fractions were dialyzed against phosphate buffer (pH 7) for 5 to 6 hr at 5 C before testing.
Electrophoresis and chromatography of the water extracts. Agar electrophoresis separated fraction B into two bands which stained with Amido Black 1OB; fraction D had only one band that stained under the same conditions. Paper chromatograms of the same fractions gave the same results. Because of the greater homogeneity of fraction D, it was used for further purification on Al(OH)3 columns. The antibiotic activity appeared in the second and third eluates. It was determined that 0.2 mg/ml of fraction D (second eluate) had good antibiotic activity (Fig. 8) .
The activity of the antibiotic was shown to be unrelated to the formation of H202, because identical inhibition zones were detected in the presence of catalase in the medium.
Physical and chemical characteristics. The antibiotic is stable from pH 2 to 8. It is readily soluble in water at neutral pH. The resultant saturated solution has a yellow-brown color, and the activity is stable at 5 C for several days. The antibiotic is precipitated from solution at pH 3. Ammonium sulfate and heavy metals also precipitate the active fraction. The white precipitate which forms redissolves readily at neutral pH. It is insoluble in most organic solvents. The purified antibiotic chars at 230 to 250 C without melting. The activity is not lost by heating at 60 C for 12 hr or by boiling for a few minutes. Neither is it destroyed by exposure to ultraviolet irradiation. It fails to pass a dialysis membrane, and it is still active after 15 to 20 hr of dialysis at 5 C.
Enzyme treatment. A 2-ml solution of fraction D (2 mg/ml) was treated for 2 to 3 hr at 37 C with various enzymes. The activity against B-263 was destroyed almost completely by trypsin, and the activity was reduced by a-amylase (Table 3) . These results would suggest a possible glycoprotein structure for the antibiotic.
Acute and chronic toxicity studies. Acute and chronic toxicity was studied in 30 albino mice treated with fraction D of the water-soluble extract. Ten mice were injected intraperitoneally with 0.1 ml of a solution containing 20 mg/ml of antibiotic. None of them died. After 10 days, the original group of mice, plus an additional 20, were injected subcutaneously over the sternum with 0.1 ml of the antibiotic (2 mg/ml). The injections were repeated every second day for 30 days. None of the mice died. All of the mice were killed 40 days after the first injection; postmortem examination of the tissues revealed no abnormalities.
DISCUSSION
These observations will become more significant if it is possible to demonstrate activity in vivo. Attention should be called to the fact that mycobactocidin is active in vitro against strains shown to be resistant to dihydrostreptomycin. Some strains of mycobacteria have been shown to develop resistance to mycobactocidin. Moreover, under certain circumstances the interaction between S. epidermidis and mycobacteria is manifested as growth enhancement. It is not known whether the enhancement effect is owing to a second factor not yet separated from the antibiotic.
